Alicia Secor Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alicia Secor.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alicia Secor. Alicia Secor is President and CEO in JUNIPER PHARMACEUTICALS INC ($JNP) and SVP, Chief Operating Officer in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in GW PHARMACEUTICALS PLC ($GWPH) and Chief Commercial Officer in ZAFGEN, INC. ($ZFGN) and Director in Orchard Therapeutics plc ($ORTX).
Latest Insider Trading Transactions of Alicia Secor
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GWPH, JNP, LRMR, ORTX, GEVA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2021 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Option Exercise | M | 0.00 | 3,144 | 4 | 0 | |
Mar 02 2021 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Payment of Exercise | F | 17.85 | 1,260 | 22,491 | 10,584 | 11.8 K to 10.6 K (-10.64 %) |
Mar 02 2021 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Buy | M | 0.00 | 3,144 | 4 | 11,844 | 8.7 K to 11.8 K (+36.14 %) |
Feb 25 2021 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Option Exercise | A | 0.00 | 22,464 | 31 | 22,464 | |
Jan 06 2021 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Option Exercise | M | 0.00 | 3,576 | 5 | 4 | |
Jan 06 2021 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Payment of Exercise | F | 9.62 | 1,440 | 13,853 | 8,700 | 10.1 K to 8.7 K (-14.20 %) |
Jan 06 2021 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Buy | M | 0.00 | 3,576 | 5 | 10,140 | 6.6 K to 10.1 K (+54.48 %) |
Jun 19 2020 | ORTX | Orchard Therapeuti ... | Secor Alicia | Director | Option Exercise | A | 7.81 | 35,000 | 273,350 | 35,000 | |
Jun 08 2020 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Option Exercise | A | 0.00 | 34,416 | 45 | 34,416 | |
Jan 07 2020 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Sell | S | 8.53 | 1,536 | 13,102 | 17,736 | 19.3 K to 17.7 K (-7.97 %) |
Apr 12 2019 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Sell | S | 14.20 | 900 | 12,780 | 19,272 | 20.2 K to 19.3 K (-4.46 %) |
Mar 15 2019 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Option Exercise | M | 0.00 | 3,580 | 5 | 0 | |
Mar 15 2019 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Buy | M | 0.00 | 3,580 | 5 | 20,172 | 16.6 K to 20.2 K (+21.58 %) |
Mar 05 2019 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Option Exercise | A | 0.00 | 3,144 | 4 | 3,144 | |
Mar 05 2019 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Option Exercise | A | 0.00 | 3,144 | 4 | 3,144 | |
Mar 05 2019 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Option Exercise | A | 0.00 | 3,144 | 4 | 3,144 | |
Mar 05 2019 | GWPH | GW PHARMACEUTICALS ... | Secor Alicia | Director | Option Exercise | A | 14.33 | 16,548 | 237,133 | 16,548 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Option Exercise | D | 7.59 | 225,000 | 1,707,750 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Option Exercise | D | 5.15 | 127,500 | 656,625 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Option Exercise | D | 7.90 | 110,000 | 869,000 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Sell | D | 11.50 | 103,855 | 1,194,333 | 0 | 103.9 K to 0 (-100.00 %) |
Mar 06 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Payment of Exercise | F | 8.80 | 1,870 | 16,456 | 86,355 | 88.2 K to 86.4 K (-2.12 %) |
Feb 09 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Payment of Exercise | F | 8.40 | 3,475 | 29,190 | 37,725 | 41.2 K to 37.7 K (-8.43 %) |
Feb 09 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Grant | A | 0.00 | 10,000 | 0 | 41,200 | 31.2 K to 41.2 K (+32.05 %) |
Mar 07 2017 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Option Exercise | A | 5.15 | 127,500 | 656,625 | 127,500 | |
Mar 07 2017 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Grant | A | 0.00 | 26,200 | 0 | 31,200 | 5 K to 31.2 K (+524.00 %) |
Aug 29 2016 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Buy | P | 5.75 | 5,000 | 28,750 | 5,000 | 0 to 5 K |
Apr 04 2016 | ZFGN | ZAFGEN, INC. | Secor Alicia | Chief Commercial Of ... | Option Exercise | A | 6.68 | 26,500 | 177,020 | 26,500 | |
Apr 04 2016 | ZFGN | ZAFGEN, INC. | Secor Alicia | Chief Commercial Of ... | Option Exercise | A | 6.68 | 53,000 | 354,040 | 53,000 | |
Sep 21 2015 | ZFGN | ZAFGEN, INC. | Secor Alicia | Chief Commercial Of ... | Option Exercise | M | 9.67 | 25,000 | 241,750 | 134,235 | |
Sep 21 2015 | ZFGN | ZAFGEN, INC. | Secor Alicia | Chief Commercial Of ... | Sell | S | 41.05 | 1,256 | 51,559 | 0 | 1.3 K to 0 (-100.00 %) |
Sep 21 2015 | ZFGN | ZAFGEN, INC. | Secor Alicia | Chief Commercial Of ... | Sell | S | 41.05 | 25,000 | 1,026,250 | 1,256 | 26.3 K to 1.3 K (-95.22 %) |
Sep 21 2015 | ZFGN | ZAFGEN, INC. | Secor Alicia | Chief Commercial Of ... | Buy | M | 9.67 | 25,000 | 241,750 | 26,256 | 1.3 K to 26.3 K (+1,990.45 %) |
Mar 03 2015 | ZFGN | ZAFGEN, INC. | Secor Alicia | Chief Commercial Of ... | Option Exercise | A | 38.65 | 60,000 | 2,319,000 | 219,235 | |
Sep 23 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Secor Alicia | SVP, Chief Operatin ... | Option Exercise | A | 53.23 | 50,000 | 2,661,500 | 50,000 |
Page: 1